Clinical trial

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

NCT01227642

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-02-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2007-02-01Date precision: month

Registry last updated2016-03-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Clinical Stage T2b or Less of Prostate Cancerunresolved

Prostate Brachytherapyunresolved

Transrectal Prostate Ultrasound Treatment Planningunresolved

Interventions

An ultrasound-based technique to identify prostate cancerOTHER

pre-implant transrectal ultrasound images and planningOTHER

ultrasound-based cancer-specific imagesOTHER

Sponsors & collaborators

Beth Israel Medical Centerlead sponsor

Riverside Research Institutecollaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01227642 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.